IMS Institute Forecasts
2015- Global Spending on Medicines est. to $1.1 Trillion

Developed markets growth slows: est. CAGR 3-6% for the next 5 years vs 6.2% in last 5 years

Why?
•US spends less
•patent expirations- spending for branded products in developed markets will remain at the same level in 2015 as in 2010.
•Market share for branded medicines drops - 70%(in 2005);64%(in 2010); 53%(in 2015)
Pharmerging Markets grow ( strong demand, govt policies)
•80 cents of every dollar spent on medicines in these markets in 2015 will be for generics.
•Pharmerging markets approach U.S. levels of spending on medicines. They will nearly double their spending on medicines, to $285-315 billion, compared with $151 billion in 2010. This will be fueled by strong economic growth and governments' commitment to expanded healthcare access.

By 2015, the pharmerging markets will become the second largest geographic segment globally in spending on medicines - surpassing EU5 and approaching U.S. levels.

Among developed markets, the U.S. will experience the largest expansion of generic spending, while Japan will continue to have the lowest share despite significant policy incentives to increase generic prescribing and dispensing.